Identification of classical minor histocompatibility antigen as cell-derived peptide.

Suppression of lymphokine production in anti-minor histocompatibility antigen responses.

Nuclear myxovirus-resistance protein Mx is a minor histocompatibility antigen.

LB-ARHGDIB-1R as a novel minor histocompatibility antigen for therapeutic application.

Minor histocompatibility antigens.

Development of a Minor Histocompatibility Antigen Vaccine Regimen in the Canine Model of Hematopoietic Cell Transplantation.

Comparison of peptide-major histocompatibility complex tetramers and dextramers for the identification of antigen-specific T cells.

Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes.

Selection of Thymocytes Expressing Transgenic TCR Specific for a Minor Histocompatibility Antigen, H60.

Cutting Edge: Roles for Batf3-Dependent APCs in the Rejection of Minor Histocompatibility Antigen-Mismatched Grafts.

Minor histocompatibility antigens: past, present, and future.

The role of H-Y as a minor transplantation antigen.

Maternally transmitted histocompatibility antigen of mice: a hydrophobic peptide of a mitochondrially encoded protein.

Enhanced binding of peptide antigen to purified class II major histocompatibility glycoproteins at acidic pH.

Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes.

Immunogenetics of graft-versus-host reactions to minor histocompatibility antigens.

Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance.

Defining novel parameters for the optimal priming and expansion of minor histocompatibility antigen-specific T cells in culture.

Memory in helper T cells of minor histocompatibility antigens, revealed in vivo by alloimmunizations in combination with Thy-1 antigen.

The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens.

Abnormal response to minor histocompatibility antigens in Obese strain chickens.

Induction of minor histocompatibility antigen-specific T-helper but not T-cytotoxic response is dependent on the source of antigen-presenting cell.

Identification of an autologous insulin B chain peptide as a target antigen for H-2Kb-restricted cytotoxic T lymphocytes.

Functional and ultrastructural evidence for intracellular formation of major histocompatibility complex class II-peptide complexes during antigen processing.

Regulation of insulin receptor functions by a peptide derived from a major histocompatibility complex class I antigen.

Suggest Documents

Suppression of lymphokine production in anti-minor histocompatibility antigen responses.

Nuclear myxovirus-resistance protein Mx is a minor histocompatibility antigen.

LB-ARHGDIB-1R as a novel minor histocompatibility antigen for therapeutic application.

Minor histocompatibility antigens.

Development of a Minor Histocompatibility Antigen Vaccine Regimen in the Canine Model of Hematopoietic Cell Transplantation.

Comparison of peptide-major histocompatibility complex tetramers and dextramers for the identification of antigen-specific T cells.

Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes.

Selection of Thymocytes Expressing Transgenic TCR Specific for a Minor Histocompatibility Antigen, H60.

Cutting Edge: Roles for Batf3-Dependent APCs in the Rejection of Minor Histocompatibility Antigen-Mismatched Grafts.

Minor histocompatibility antigens: past, present, and future.

The role of H-Y as a minor transplantation antigen.

Maternally transmitted histocompatibility antigen of mice: a hydrophobic peptide of a mitochondrially encoded protein.

Enhanced binding of peptide antigen to purified class II major histocompatibility glycoproteins at acidic pH.

Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes.

Immunogenetics of graft-versus-host reactions to minor histocompatibility antigens.

Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance.

Defining novel parameters for the optimal priming and expansion of minor histocompatibility antigen-specific T cells in culture.

Memory in helper T cells of minor histocompatibility antigens, revealed in vivo by alloimmunizations in combination with Thy-1 antigen.

The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens.

Abnormal response to minor histocompatibility antigens in Obese strain chickens.

Induction of minor histocompatibility antigen-specific T-helper but not T-cytotoxic response is dependent on the source of antigen-presenting cell.

Identification of an autologous insulin B chain peptide as a target antigen for H-2Kb-restricted cytotoxic T lymphocytes.

Functional and ultrastructural evidence for intracellular formation of major histocompatibility complex class II-peptide complexes during antigen processing.

Regulation of insulin receptor functions by a peptide derived from a major histocompatibility complex class I antigen.

Identification of classical minor histocompatibility antigen as cell-derived peptide.

Recommend Documents

Follow Us